Boston Scientific Corporation (BSX) Release: TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program (Biospace, 13 May 2008)

Head of Communications & Campaigns - Meningitis Research Foundation

Unpublished data shows breast cancer drug 'third less effective' (Guardian, 16 May 2008)

16 May 2008

A group of doctors from Pharmaceutical Management Agency have revealed the literature on the breast cancer drug Herceptin shows a 'publication bias' by drug companies, in failing to publish negative results.

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read